tiprankstipranks
Ondine Biomedical, Inc. (DE:VF5)
FRANKFURT:VF5
Germany Market
VF5
Ondine Biomedical, Inc.
RESEARCH TOOLSreports

Ondine Biomedical, Inc. (VF5) Financial Statements

2 Followers

Ondine Biomedical, Inc. Financial Overview

Ondine Biomedical, Inc.'s market cap is currently €88.13M. The company's EPS TTM is €-0.064; its P/E ratio is -3.98; Ondine Biomedical, Inc. is scheduled to report earnings on June 4, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 2.65MC$ 2.05MC$ 1.20MC$ 638.00KC$ 2.57M
Gross ProfitC$ 1.09MC$ 1.32MC$ 703.00KC$ 287.00KC$ 1.25M
Operating IncomeC$ -30.04MC$ -19.44MC$ -14.80MC$ -18.76MC$ -17.52M
EBITDAC$ -29.45MC$ -18.49MC$ -13.79MC$ -18.85MC$ -48.36M
Net IncomeC$ -29.59MC$ -19.10MC$ -14.41MC$ -19.37MC$ -50.09M
Balance Sheet
Cash & Short-Term InvestmentsC$ 10.58MC$ 9.77MC$ 2.98MC$ 13.13MC$ 30.36M
Total AssetsC$ 14.40MC$ 12.82MC$ 5.73MC$ 16.57MC$ 34.14M
Total DebtC$ 413.50KC$ 168.00KC$ 541.00KC$ 896.00KC$ 739.00K
Net DebtC$ -10.17MC$ -9.60MC$ -2.44MC$ -12.23MC$ -29.63M
Total LiabilitiesC$ 10.91MC$ 5.95MC$ 3.65MC$ 4.92MC$ 4.48M
Stockholders' EquityC$ 3.49MC$ 6.88MC$ 2.08MC$ 11.64MC$ 29.66M
Cash Flow
Free Cash FlowC$ -24.02MC$ -15.50MC$ -13.83MC$ -16.66MC$ -12.62M
Operating Cash FlowC$ -23.90MC$ -15.49MC$ -13.65MC$ -16.34MC$ -12.54M
Investing Cash FlowC$ -117.28KC$ -10.00KC$ -177.00KC$ -311.00KC$ -77.00K
Financing Cash FlowC$ 24.28MC$ 21.74MC$ 3.79MC$ -275.00KC$ 41.90M
Currency in CAD

Ondine Biomedical, Inc. Earnings and Revenue History

Income Statement >

Ondine Biomedical, Inc. Debt to Assets

Balance Sheet >

Ondine Biomedical, Inc. Cash Flow

Cash Flow >

Ondine Biomedical, Inc. Forecast EPS vs Actual EPS

Earnings >